Fulcrum Therapeutics, Inc. (FULC)
3.535
+0.02
(+0.71%)
USD |
NASDAQ |
Jun 11, 16:00
3.535
0.00 (0.00%)
After-Hours: 19:33
Fulcrum Therapeutics Price : 3.535 for June 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 3.50 | 3.64 | 3.34 | 3.51 | 2.460M |
| Jun 09, 2026 | 3.49 | 3.62 | 3.36 | 3.52 | 3.985M |
| Jun 08, 2026 | 3.505 | 3.63 | 3.36 | 3.44 | 3.314M |
| Jun 05, 2026 | 3.36 | 3.70 | 3.30 | 3.69 | 3.955M |
| Jun 04, 2026 | 3.29 | 3.39 | 3.21 | 3.37 | 4.816M |
| Jun 03, 2026 | 3.11 | 3.27 | 3.09 | 3.22 | 5.599M |
| Jun 02, 2026 | 3.112 | 3.26 | 2.83 | 3.14 | 32.80M |
| Jun 01, 2026 | 7.02 | 7.02 | 6.38 | 6.42 | 3.121M |
| May 29, 2026 | 6.83 | 7.07 | 6.71 | 6.92 | 391024.0 |
| May 28, 2026 | 6.78 | 6.83 | 6.68 | 6.82 | 313647.0 |
| May 27, 2026 | 6.76 | 7.00 | 6.74 | 6.78 | 325992.0 |
| May 26, 2026 | 6.58 | 6.79 | 6.455 | 6.76 | 375124.0 |
| May 22, 2026 | 6.72 | 6.77 | 6.525 | 6.57 | 306212.0 |
| May 21, 2026 | 6.31 | 6.64 | 6.22 | 6.59 | 402631.0 |
| May 20, 2026 | 5.97 | 6.405 | 5.97 | 6.35 | 518173.0 |
| May 19, 2026 | 6.04 | 6.10 | 5.88 | 5.91 | 492191.0 |
| May 18, 2026 | 6.69 | 6.810 | 6.08 | 6.09 | 572914.0 |
| May 15, 2026 | 6.98 | 7.025 | 6.63 | 6.69 | 431144.0 |
| May 14, 2026 | 7.28 | 7.32 | 6.91 | 7.11 | 501071.0 |
| May 13, 2026 | 6.95 | 7.28 | 6.855 | 7.25 | 535713.0 |
| May 12, 2026 | 7.01 | 7.135 | 6.89 | 6.96 | 598664.0 |
| May 11, 2026 | 7.21 | 7.50 | 6.93 | 7.00 | 633954.0 |
| May 08, 2026 | 6.88 | 7.13 | 6.82 | 7.01 | 646186.0 |
| May 07, 2026 | 7.11 | 7.14 | 6.85 | 6.88 | 459330.0 |
| May 06, 2026 | 7.06 | 7.195 | 7.00 | 7.11 | 546676.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.02 |
| CNBX Pharmaceuticals, Inc. | 0.0002 |
| GB Sciences, Inc. | 0.0004 |
| Arvinas, Inc. | 7.085 |
| Definium Therapeutics, Inc. | 24.10 |
Price Related Metrics
| PEG Ratio | -0.0019 |
| Price to Book Value | 0.7064 |
| Earnings Yield | -32.43% |
| Market Cap | 235.46M |
| PEGY Ratio | -0.0019 |